Go to content
UR Home

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval

URN to cite this document:
DOI to cite this document:
Michel, Holger ; Potapow, Antonia ; Dechant, Markus-Johann ; Brandstetter, Susanne ; Wellmann, Sven ; Köninger, Angela ; Melter, Michael ; Apfelbacher, Christian J. ; Kabesch, Michael ; Gerling, Stephan
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 09 Aug 2023 08:16


Introduction: Acquired QT interval prolongations due to drug side effects can result in detrimental arrhythmia. Maternal use of placenta-permeable drugs may lead to fetal exposure, thus leading to an increased risk of neonatal QT prolongation and arrhythmia. Objectives: This study aimed to evaluate the influence of maternal QT-prolonging medication on the neonatal QT interval. Methods: In ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons